Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Not Applicable

• Conditions: Trismus; Edema; Pain
• Interventions: Drug: Etodalac, Etoricoxib and Dexamethasone

• Registration Number: NCT00793052
• Lead Sponsor: Tel-Aviv Sourasky Medical Center

Brief Summary

The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-10-29
• Status Verified: 2008-11
• Study Start: 2008-11
• Study First Submitted QC: 2008-11-16
• Last Update Submitted: 2008-11-16
• Study First Posted: 2008-11-19
• Last Update Posted: 2008-11-19
• Primary Completion: 2009-12
• Study Completion: 2009-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Patients who are refered for third molar extraction to our center
• Must be able to swallow tablets

Exclusion Criteria

• Diabetes mellitus
• Thyroid diseases
• Cardiovascular diseases
• renal diseases
• hepatic diseases
• respiratory system diseases
• adrenal diseases
• Allergy to Etodalac, Etoricoxib or Dexamethasone
• Gastric ulcers
• psychiatric diseases
• Pregnant or breast feeding womans

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
A	Etodalac, Etoricoxib and Dexamethasone	-

Primary Outcome Measures

Name	Time	Method
PAIN- By VAS graded from 1-10 TRISMUS- By MAX mouth opening from the first incisors adages POST OPERATIVE SWELLing - By measurement the distance between the Right and LEFT ear's tragus	1 week